medigraphic.com
ISSN 1561-3054 (Electronic)

2021, Number 3

Next >>

Rev Cubana Med Trop 2021; 73 (3)

Evaluation of seven SARS-CoV-2 rapid IgM/IgG tests

Pelegrino MJL, Rodriguez LLA, Tejero SY, Valdés RO, Resik AS, Calderón FO, Ugarte PY, de León GJC, Morales VDD, Guzmán TMG

Language: English
References: 14
Page: 1-12
PDF size: 422.48 Kb.


ABSTRACT

Introduction: In late 2019, a new coronavirus was detected in China causing an acute respiratory illness known as COVID-2019.
Objective: Evaluate seven commercial systems for the rapid detection of antibodies to determine their sensitivity, specificity and robustness in our conditions to be used by the National Health System.
Methods: Seven systems were evaluated for the detection of IgM/IgG antibodies. Evaluation panel with samples from negative individuals, sera from other pathologies prior to the pandemic and from positive patients with the disease were conformed.
Results: General sensitivity figures range between 25 and 88%, with the Realy Tech and Deep Blue systems showed the best results. The specificity for both was 100%. The IgM positive rate according to Realy Tech or Deep Blue increased to 94.1 or 81.8% in the late stage of the disease.
Conclusions: Realy Tech and Deep Blue systems detected IgM/IgG in serum and in whole blood with adequate sensitivity and specificity. Cross-reactivity does not seem to be a problem. Serology in the case of COVID-19 cannot be used as a diagnostic but it allows epidemiological surveillance to know the immune status of populations. It’s essential to analyze the immune response against the infection to carry out epidemiological characterization and potentially inform individual risk of future disease and the study of potential vaccines.


REFERENCES

  1. Zhonghua Liu, Xing Bing, Xue Za Zhi. Novel Coronavirus Pneumonia Emergency Response Epidemiology. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chinese Medical Association. 2020;41:145-51. DOI: https://doi.org/10.3760/cma.j.issn.0254-6450.2020.02.003

  2. WHO. Coronavirus (COVID-19) Dashboard. [acceso: 01/01/2021]. Disponible en: Disponible en: https://covid19.who.int/

  3. Lin Ch, Ding Y, Xie B, Sun Z, Li X, Chen Z, et al. Asymptomatic novel coronavirus pneumonia patient outside Wuhan: The value of CT images in the course of the disease. Clinical Imaging. 2020;63:7-9.

  4. Sethuraman N, Stanleyraj S, Ryo A. Interpreting Diagnostic Tests for SARS-CoV-2. JAMA. 9 June 2020;323(22):2249-51. DOI: https://doi.org/10.1001/jama.2020.8259

  5. Wang W, Xu Y, Gao R. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 11 March 2020;323(18):1843-44. DOI: https://doi.org/10.1001/jama.2020.3786

  6. Zhang W, Du RH, Li B. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020;9:386-9.

  7. Meyer B, Drosten C, Muller MA. Serological assays for emerging coronaviruses: challenges and pitfalls. Virus Res. 2014;194:175-83.

  8. Guadis Salazar E, Rodriguez LL, Montalvo Villalba M, Bello Corredor M, López Hernandez D. Android applications for viral hepatitis diagnosis, research and training. J Intern AIDS Soc. 2018;21(S3):44:e25093

  9. Winter AK, Hegde ST. The important role of serology for COVID-19 control. Lancet Infect Dis. 2020 Jul;20(7):758-9. DOI: https://doi.org/10.1016/S1473­3099(20)30322­4

  10. Chen Z, Sun K, Pan W, Zhan Z, Chen L, Ye F. Development and Clinical Application of A Rapid IgM-IgG Combined Antibody Test for SARS-CoV-2 Infection Diagnosis. J Med Virol. 27 Feb 2020 [acceso: 01/01/2021];92:1518-24. Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.25727

  11. Long Q, Liu B, Deng H. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. June 2020;26:845-8. DOI: https://doi.org/10.1038/s41591-020-0897-1

  12. Liu L, Liu W, Zheng Y, Jiang X, Kou G, Ding J, et al. A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients. Microbes Infect. May-Jun 2020;22(4-5):206-11. DOI: https://doi.org/10.1016/j.micinf.2020.05.008

  13. Lisboa M, Tavaziva G, Kunal Abidi S, Campbell JR, Haraoui LP, Johnston JC, et al. Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis. BMJ. 2020;370:2516. DOI: https://doi.org/10.1136/bmj.m2516

  14. Mercado M, Malagón-Rojas J, Delgado G, Rubio VV, Muñoz Galindo L, Parra Barrera EL, et al. Evaluation of nine serological rapid tests for the detection of SARS-CoV-2. Rev Panam Salud Publica. 2020;44:e149. DOI: https://doi.org/10.26633/RPSP.2020.149




2020     |     www.medigraphic.com